The utilization of surgical meshes for temporary and permanent reinforcement has increased as a result of their availability in absorbable and non-absorbable forms. As they reduce the risk of implant exposure, surgical meshes have been increasingly popular in recent years as a tool for breast reconstruction. Numerous chronic health problems are a result of sedentary lifestyles and rising obesity rates in the community. Because of the resulting muscular weakness, there is more room for organ prolapse and hernia. Muscle tearing and the return of prolapse can occur when these organs are put back in place by sewing the muscles together. However, it has been demonstrated that strengthening the weaker muscles with the use of a surgical mesh can reduce recurrence and lengthen the duration of the repair.
Medical care that is given on an outpatient basis is known as ambulatory care or outpatient care. Surgery conducted as part of outpatient treatment is often less invasive than hospital surgeries, according to an article headlined "The Difference Between Inpatient and Outpatient." Surgery for the ears, eyes, mouth, nose, and throat is usually performed as an outpatient procedure. Most patients leave between one and four hours after an outpatient operation. In light of the fact that shorter recovery times are one of the most crucial requirements in ambulatory care, the surgical polypropylene mesh market is seeing massive development.
Inhibited Recurrence Rate in Hernia Repair with Surgical Mesh to Increase Demand
A number of factors, including an increase in hernia cases, increased awareness of the benefits of implanting mesh material during corrective surgeries, technological developments in surgical mesh, an increase in risk factors like obesity, and shifting lifestyle trends, are expected to drive market growth. According to data from the Healthcare Cost and Utilization Project and the United States Food and Drug Administration, approximately 611,000 ventral and 1 million inguinal hernia repairs are conducted annually in the United States. Globally, hernia repair procedures exceed 20 million each year, highlighting the extensive demand for surgical mesh in this crucial sector. Thus, it is anticipated that the market would expand more quickly due to the rising frequency of hernia cases and other issues associated with them.
The prevalence of abdominal wall hernia was 1.7% globally for all ages, according to a different article published in April 2022 titled "Prevalence and associated factors of external hernia among adult patients visiting the surgical outpatient department at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a cross-sectional study." More than 20 million hernias are operated on each year globally, accounting for 15% to 18% of all surgical procedures. The rising number of hernia operations is anticipated to encourage increased utilisation of surgical polypropylene mesh and, as a result, to encourage market expansion over the course of the forecast period.
Recent Trends in the Surgical Mesh Industry:
- Reduced frequency of hernia returns in surgeries using mesh is expected to increase the need for surgical mesh.
- Customize products based on specific site requirements with various shapes, sizes, and textures.
- Recent innovations in biomaterials, such as bioabsorbable meshes, enhance safety and integration.
- The industry increasingly focuses on surgical meshes for minimally invasive laparoscopic and robotic surgeries.
- Integration of regenerative medicine, including tissue engineering and stem cells, enhances mesh performance.
Explore Our Breakthrough Market Segmentation and Personalize
it to Meet Your Business Needs…!
Surgical Mesh Market Restrained by Regulatory Burdens and Legal Risks of High-Profile Lawsuits
Stringent regulations imposed by regulatory bodies such as the FDA and EMA necessitate rigorous compliance, involving extensive clinical trials and comprehensive documentation. This regulatory burden can slow the approval process and restrain market expansion. Additionally, high-profile recalls and legal issues related to surgical mesh products restricting from complications like infections, organ perforations, and chronic pain have intensified scrutiny. Such incidents, including recent high-profile lawsuits like the July 2024 case in Massachusetts involving Boston Scientific's Obtryx II sling system, contribute to reduced confidence among patients and healthcare providers.
In this case, the plaintiff, who experienced severe pain and complications following the implantation of a pelvic mesh, highlights the adverse effects that can result from mesh-related issues. Persistent symptoms such as vaginal dryness, chronic pain, and mesh erosion led to ongoing medical interventions and significantly affected the plaintiff’s quality of life. This lawsuit underscores the potential for increased legal and reputational risks, further hindering market growth. The high cost of advanced meshes, variations in reimbursement policies, and the rise of alternative treatments also add to the challenges, potentially limiting market adoption and expansion.
New Reinforced Tissue Matrix and Compact Mesh Redefine Standards in Hernia Surgery
Major industry leaders utilize strategies that focus on launching new products, merging with competitors, and purchasing companies to grow their customer base and enhance their range of products. In April 2024, TELA Bio, a medical technology company located in Pennsylvania, introduced its OviTex Inguinal Hernia Repair (IHR) Reinforced Tissue Matrix in the United States. This new surgical mesh is tailored for laparoscopic and inguinal hernia repairs, featuring robotic-compatible designs in three configurations: a three- or four-layer anatomically shaped device, and a three-layer rectangular option. OviTex IHR builds on TELA Bio's OviTex portfolio, which combines ovine rumen with minimal polymer for enhanced strength. This launch addresses gaps in the hernia repair market dominated by permanent synthetic meshes, offering a more adaptable and patient-friendly solution.
Furthermore, in March 2024, the surgical mesh market saw a significant advancement with the anticipated launch of the T-Line Mini by Deep Blue. Scheduled for April 2024, this condensed edition is designed for umbilical hernias and minor defects. Additionally, the company is innovating with biosynthetic and coated composite variations of the T-Line Hernia Mesh. These new products address the growing preference for meshes that are absorbed over time and those designed to minimize abdominal adhesions. Following the original T-Line Hernia Mesh launch, Deep Blue has engaged extensively with surgeons and key opinion leaders to refine and enhance their offerings.
Know Your Competitors and Strengthen Market Share
Effectively
North America Dominates the Global Surgical Polypropylene Mesh Market During the Forecast Period
Diverticulosis is fairly prevalent, especially as individuals age, according to an article titled "Definition & Facts about Diverticular Disease" that was publishe. Diverticulosis affects more than 30% of 50 to 59-year-old Americans and more than 70% of people over the age of 80. Every year, diverticulitis causes the hospitalisation of roughly 200,000 Americans. 2 Diverticular bleeding sends over 71,000 patients to the hospital every year. Thus, it is anticipated that the demand for surgical polypropylene mesh for surgical operations would rise as diverticulosis instances in the nation and area rise. To service the market under investigation, the firms also work in direct channel partnership with hospitals and clinics that is well-established. Similarly, according to an article named "Ulcerative Colitis" that was published in June 2022, there are 9 to 20 instances of ulcerative colitis for every 100,000 people per year. Between 156 and 291 cases per 100,000 people are reported annually. In adults in the United States, ulcerative colitis is more common than Crohn's disease. Therefore, it is anticipated that the market in the area will be driven by the rising prevalence of ulcerative colitis.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the surgical mesh market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for surgical mesh market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the surgical mesh market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the surgical mesh market. Some key country and region included in the surgical mesh market report as follows:
Regions |
Countries |
North America |
United States, Canada |
Latin America |
Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
Europe |
Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
Asia Pacific |
China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
Middle East and Africa |
GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Surgical Mesh Market Research Report Covers In-depth Analysis on:
- Surgical mesh market detailed segments and segment-wise market breakdown
- Surgical mesh market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in surgical mesh industry)
- Current, historical and forthcoming 10 years market valuation in terms of surgical mesh market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Surgical mesh market demand analysis
- Surgical mesh market pricing analysis over forecast period (by key segment and by region)
- Surgical mesh market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in surgical mesh market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in surgical mesh market
- Surgical mesh market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on surgical mesh market forecast by countries
- Mergers and acquisitions in surgical mesh market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the key drivers of growth in the surgical mesh market?
The primary drivers include the rise in surgeries, advancements in mesh technology and the growing prevalence of hernias and pelvic organ prolapse.
What challenges are faced by the surgical mesh market?
Challenges include complications associated with mesh implants, regulatory hurdles and the need for rigorous clinical trials to ensure product safety.
Which regions are seeing the most significant growth in the surgical mesh market?
North America and Europe are leading due to advanced healthcare infrastructure, but Asia-Pacific is emerging rapidly due to increased healthcare investments and rising surgical procedures.